SK Chemicals Co., Ltd. - Product Pipeline Review - 2016

Published: May, 2016 | Pages: 52 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

SK Chemicals Co., Ltd. - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'SK Chemicals Co., Ltd. - Product Pipeline Review - 2016', provides an overview of the SK Chemicals Co., Ltd.'s pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by SK Chemicals Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of SK Chemicals Co., Ltd.
- The report provides overview of SK Chemicals Co., Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses SK Chemicals Co., Ltd.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features SK Chemicals Co., Ltd.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate SK Chemicals Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for SK Chemicals Co., Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding SK Chemicals Co., Ltd.'s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope

 Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 5
SK Chemicals Co., Ltd. Snapshot 6
SK Chemicals Co., Ltd. Overview 6
Key Information 6
Key Facts 6
SK Chemicals Co., Ltd. - Research and Development Overview 7
Key Therapeutic Areas 7
SK Chemicals Co., Ltd. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
SK Chemicals Co., Ltd. - Pipeline Products Glance 14
SK Chemicals Co., Ltd. - Late Stage Pipeline Products 14
Pre-Registration Products/Combination Treatment Modalities 14
Phase III Products/Combination Treatment Modalities 15
SK Chemicals Co., Ltd. - Clinical Stage Pipeline Products 16
Phase I Products/Combination Treatment Modalities 16
SK Chemicals Co., Ltd. - Early Stage Pipeline Products 17
Preclinical Products/Combination Treatment Modalities 17
Discovery Products/Combination Treatment Modalities 18
SK Chemicals Co., Ltd. - Drug Profiles 19
antihemophilic factor (recombinant) 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
NBP-603 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
NBP-606 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
NBP-607 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
THVD-201 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
NBP-608 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
NCE-403 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
SKI-2670 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
NBP-604 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
NBP-611 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
NCE-401 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
NCE-402 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
NCE-405 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
SID-111 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
SID-910 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
SID-920 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
SKI-2162 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
typhoid vaccine 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Vaccine 2 for Undisclosed Indication 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
pneumonia vaccine 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
SK Chemicals Co., Ltd. - Pipeline Analysis 40
SK Chemicals Co., Ltd. - Pipeline Products by Target 40
SK Chemicals Co., Ltd. - Pipeline Products by Route of Administration 41
SK Chemicals Co., Ltd. - Pipeline Products by Molecule Type 42
SK Chemicals Co., Ltd. - Pipeline Products by Mechanism of Action 43
SK Chemicals Co., Ltd. - Recent Pipeline Updates 44
SK Chemicals Co., Ltd. - Dormant Projects 47
SK Chemicals Co., Ltd. - Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Appendix 51
Methodology 51
Coverage 51
Secondary Research 51
Primary Research 51
Expert Panel Validation 51
Contact Us 51
Disclaimer 52

List of Tables

SK Chemicals Co., Ltd., Key Information 6
SK Chemicals Co., Ltd., Key Facts 6
SK Chemicals Co., Ltd. - Pipeline by Indication, 2016 9
SK Chemicals Co., Ltd. - Pipeline by Stage of Development, 2016 10
SK Chemicals Co., Ltd. - Monotherapy Products in Pipeline, 2016 11
SK Chemicals Co., Ltd. - Partnered Products in Pipeline, 2016 12
SK Chemicals Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2016 13
SK Chemicals Co., Ltd. - Pre-Registration, 2016 14
SK Chemicals Co., Ltd. - Phase III, 2016 15
SK Chemicals Co., Ltd. - Phase I, 2016 16
SK Chemicals Co., Ltd. - Preclinical, 2016 17
SK Chemicals Co., Ltd. - Discovery, 2016 18
SK Chemicals Co., Ltd. - Pipeline by Target, 2016 40
SK Chemicals Co., Ltd. - Pipeline by Route of Administration, 2016 41
SK Chemicals Co., Ltd. - Pipeline by Molecule Type, 2016 42
SK Chemicals Co., Ltd. - Pipeline Products by Mechanism of Action, 2016 43
SK Chemicals Co., Ltd. - Recent Pipeline Updates, 2016 44
SK Chemicals Co., Ltd. - Dormant Developmental Projects,2016 47
SK Chemicals Co., Ltd., Other Locations 48
SK Chemicals Co., Ltd., Subsidiaries 49